ATE538201T1 - Kcnb: ein kaliumkanalprotein - Google Patents
Kcnb: ein kaliumkanalproteinInfo
- Publication number
- ATE538201T1 ATE538201T1 AT01924111T AT01924111T ATE538201T1 AT E538201 T1 ATE538201 T1 AT E538201T1 AT 01924111 T AT01924111 T AT 01924111T AT 01924111 T AT01924111 T AT 01924111T AT E538201 T1 ATE538201 T1 AT E538201T1
- Authority
- AT
- Austria
- Prior art keywords
- kcnb
- potassium channel
- channel protein
- activity
- modulate
- Prior art date
Links
- 102000004257 Potassium Channel Human genes 0.000 title abstract 2
- 108020001213 potassium channel Proteins 0.000 title abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 108091005461 Nucleic proteins Chemical group 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical group 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 238000011895 specific detection Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Psychology (AREA)
- Hematology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18691500P | 2000-03-03 | 2000-03-03 | |
| PCT/US2001/006801 WO2001066741A2 (en) | 2000-03-03 | 2001-03-02 | Kcnb: a novel potassium channel protein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE538201T1 true ATE538201T1 (de) | 2012-01-15 |
Family
ID=22686808
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01924111T ATE538201T1 (de) | 2000-03-03 | 2001-03-02 | Kcnb: ein kaliumkanalprotein |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US7462465B2 (enExample) |
| EP (1) | EP1266003B1 (enExample) |
| JP (2) | JP2004500825A (enExample) |
| CN (1) | CN1426468A (enExample) |
| AT (1) | ATE538201T1 (enExample) |
| AU (2) | AU2001250794B2 (enExample) |
| CA (1) | CA2401906C (enExample) |
| ES (1) | ES2378417T3 (enExample) |
| IL (2) | IL151564A0 (enExample) |
| NZ (1) | NZ521205A (enExample) |
| WO (1) | WO2001066741A2 (enExample) |
| ZA (1) | ZA200206999B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003057846A2 (en) * | 2001-12-31 | 2003-07-17 | Algos Therapeutics, Inc. | Methods and materials for modulating task-3 |
| WO2005052586A2 (en) * | 2003-11-27 | 2005-06-09 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with potassium channel, subfamily k, member 3 (kcnk3) |
| WO2005075510A1 (en) * | 2004-02-04 | 2005-08-18 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with potassium channel, subfamily k, member 9 (kcnk9) |
| US12416024B2 (en) | 2018-03-29 | 2025-09-16 | Transworld Technologies Inc. | Biologically enhanced oil recovery methods |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2744730B1 (fr) | 1996-02-08 | 1998-04-17 | Centre Nat Rech Scient | Nouvelle famille de canaux potassium de mammifere, leur clonage et leur utilisation notamment pour le criblage de drogues |
| EP1051485A1 (en) | 1998-01-27 | 2000-11-15 | Smithkline Beecham Plc | Trek-1 like two pore potassium channel |
| EP1090118A2 (en) * | 1998-06-26 | 2001-04-11 | Incyte Pharmaceuticals, Inc. | Human signal peptide-containing proteins |
| DE69938667D1 (de) | 1998-11-09 | 2008-06-19 | Centre Nat Rech Scient | Neue familie von säugetier-kaliumkanälen, ihre klonierung und ihre verwendung, besonders für das drogenscreening |
| WO2000053628A2 (en) * | 1999-03-05 | 2000-09-14 | Smithkline Beecham Plc | Genes encoding human potassium channel proteins |
| US20020137202A1 (en) * | 1999-12-21 | 2002-09-26 | Catherine Burgess | Novel proteins and nucleic acids encoding same |
| GB2373500B (en) | 2000-02-04 | 2004-12-15 | Aeomica Inc | Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence |
| EP1381626A2 (en) | 2000-04-06 | 2004-01-21 | Incyte Genomics, Inc. | Human transporters and ion channels |
| AU2001294724A1 (en) | 2000-09-25 | 2002-04-08 | Millennium Pharmaceuticals, Inc. | 56115, a novel human twik potassium channel and uses therefor |
-
2001
- 2001-03-02 CN CN01808748A patent/CN1426468A/zh active Pending
- 2001-03-02 AU AU2001250794A patent/AU2001250794B2/en not_active Ceased
- 2001-03-02 AT AT01924111T patent/ATE538201T1/de active
- 2001-03-02 NZ NZ521205A patent/NZ521205A/en unknown
- 2001-03-02 JP JP2001565895A patent/JP2004500825A/ja active Pending
- 2001-03-02 WO PCT/US2001/006801 patent/WO2001066741A2/en not_active Ceased
- 2001-03-02 US US09/798,584 patent/US7462465B2/en not_active Expired - Fee Related
- 2001-03-02 ES ES01924111T patent/ES2378417T3/es not_active Expired - Lifetime
- 2001-03-02 IL IL15156401A patent/IL151564A0/xx unknown
- 2001-03-02 EP EP01924111A patent/EP1266003B1/en not_active Expired - Lifetime
- 2001-03-02 CA CA2401906A patent/CA2401906C/en not_active Expired - Lifetime
- 2001-03-02 AU AU5079401A patent/AU5079401A/xx active Pending
-
2002
- 2002-08-30 ZA ZA200206999A patent/ZA200206999B/en unknown
- 2002-09-02 IL IL151564A patent/IL151564A/en not_active IP Right Cessation
-
2008
- 2008-01-03 US US11/968,795 patent/US20080234470A1/en not_active Abandoned
-
2011
- 2011-01-13 JP JP2011005342A patent/JP2011115169A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US7462465B2 (en) | 2008-12-09 |
| CA2401906A1 (en) | 2001-09-13 |
| JP2011115169A (ja) | 2011-06-16 |
| ES2378417T3 (es) | 2012-04-12 |
| CN1426468A (zh) | 2003-06-25 |
| US20080234470A1 (en) | 2008-09-25 |
| ZA200206999B (en) | 2004-05-31 |
| NZ521205A (en) | 2005-09-30 |
| AU5079401A (en) | 2001-09-17 |
| IL151564A (en) | 2008-11-03 |
| WO2001066741A9 (en) | 2003-03-06 |
| WO2001066741A2 (en) | 2001-09-13 |
| WO2001066741A3 (en) | 2002-04-04 |
| JP2004500825A (ja) | 2004-01-15 |
| EP1266003B1 (en) | 2011-12-21 |
| CA2401906C (en) | 2011-07-19 |
| AU2001250794B2 (en) | 2006-03-02 |
| IL151564A0 (en) | 2003-04-10 |
| EP1266003A2 (en) | 2002-12-18 |
| US20020102676A1 (en) | 2002-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2085502A (en) | Diagnosis and treatment of disease | |
| DE60330842D1 (de) | Für den nachweis von nukleinsäuren kompetente biologische rohderivate | |
| DE60322880D1 (de) | Einfache katalytische dna-biosensoren für ionen auf grundlage von farbveränderungen | |
| SE0003286D0 (sv) | Method and kit for human identification | |
| DE60041355D1 (de) | Verfahren zur detektion von erkrankungen | |
| ATE322558T1 (de) | Sensible und multiplexe diagnostische tests zur proteinanalyse | |
| DK1268847T3 (da) | Ubiquitin-ligaseassay | |
| DE60230672D1 (de) | Nukleinsäureanreicherung | |
| ATE309536T1 (de) | Methoden zur verwendung von randomisierten zinkfingerprotein-bibliotheken zur identifizierung von genfunktionen | |
| DK1389241T3 (da) | Polynucleotid-sekventeringsfremgangsmåde | |
| DE69937835D1 (de) | Antikörper für apoptosemarker und anwendungsverfahren | |
| ATE439441T1 (de) | Veränderte, fluoreszierende proteine | |
| DE60108337D1 (de) | Methode und testsatz zur detektion von schistosomiasis mittels polymerasekettenreaktion | |
| IL179441A0 (en) | Hif prolyl hydroxylase activity assay | |
| CU23302A1 (es) | Medio de cultivo selectivo para el aislamiento y detecciã"n de especies del gã0/00nero streptococcus | |
| TR200501541T2 (tr) | Leu-hirudinin e.coli ile kültür ortamında ayrışarak üretilmesinin sinyal sekansları | |
| ATE389881T1 (de) | Detektion von kleinen molekülen mit piezo- elektrischem sensor | |
| ATE538201T1 (de) | Kcnb: ein kaliumkanalprotein | |
| ATE389018T1 (de) | Cx3c chemokin-gene von säugetieren | |
| ATE288589T1 (de) | Verfahren zur analyse von proteinen | |
| ATE456666T1 (de) | Verfahren zur auswertung von ribonukleotidsequenzen | |
| WO2004070012A3 (en) | Cell-killing molecules and methods of use thereof | |
| ATE309370T1 (de) | Retinoid-metabolisierendes protein | |
| DE60015319D1 (de) | Test zur gleichzeitigen messung von verschiedenen enzymatischen aktivitäten | |
| DE60121547D1 (de) | Electrochemisches verfahren zum nachweis von nukleinsäuren |